Myasthenia Gravis Foundation of America (MGFA) re-launches the ...

EurekAlert - 25 Jan 2023
Patients living with myasthenia gravis (MG) provide their health and symptom experience data in a safe, secure registry to drive new research and ...

Myasthenia Gravis: Advice for the Generalist

Medscape - 03 Apr 2024
Myasthenia Gravis: Advice for the Generalist ...

Changing the darkness of medical trauma into gold

Myasthenia Gravis News - 19 Apr 2024
Changing the darkness of medical trauma into gold ...

Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital ...

Nature.com - 27 Mar 2024
Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital ... ...

Argenx gears up to launch Vyvgart in next potential indication

FiercePharma - 16 Apr 2024
Argenx gears up to launch Vyvgart in next potential indication ...

Myasthenia Gravis: New Drugs and a Road to Individualized Treatment

Yale Medicine - 17 Nov 2023
Myasthenia Gravis: New Drugs and a Road to Individualized Treatment ...

Ocular Myasthenia Gravis As Unilateral Ptosis and External Ophthalmoplegia: A Case Report

Cureus - 17 Mar 2024
Ocular Myasthenia Gravis As Unilateral Ptosis and External Ophthalmoplegia: A Case Report ...

Addressing Juvenile Generalized Myasthenia Gravis

Medpage Today - 22 Dec 2023
Addressing Juvenile Generalized Myasthenia Gravis ...

Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

AJMC.com Managed Markets Network - 15 Apr 2024
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG ...

Presentation of Myasthenia Gravis (MG)

Neurology Live - 26 Mar 2024
Presentation of Myasthenia Gravis (MG) ...

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

GlobalData - 31 Oct 2023
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 ...

5 things we now know about myasthenia gravis

Johnson & Johnson - 29 Jun 2023
5 things we now know about myasthenia gravis ...

AAN 2024: Benefits of Ultomiris sustained for more than 3 years

Myasthenia Gravis News - 18 Apr 2024
AAN 2024: Benefits of Ultomiris sustained for more than 3 years ...

Myasthenia gravis: the changing treatment landscape in the era of molecular therapies

Nature.com - 08 Jan 2024
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies ...

Promising Results for Investigational Myasthenia Gravis Drug

Medscape - 13 Mar 2024
Promising Results for Investigational Myasthenia Gravis Drug ...

Despite positive trial, Roche says Enspryng fell short of expectations in myasthenia gravis

FiercePharma - 21 Mar 2024
Despite positive trial, Roche says Enspryng fell short of expectations in myasthenia gravis ...

Review: Vigilance Warranted to Prevent, Treat Transient Neonatal Myasthenia Gravis

AJMC.com Managed Markets Network - 08 Mar 2024
Review: Vigilance Warranted to Prevent, Treat Transient Neonatal Myasthenia Gravis ...

Episode 6: Managing Myasthenia Gravis in Primary Care: Best Practices

Medscape - 24 Oct 2023
Episode 6: Managing Myasthenia Gravis in Primary Care: Best Practices ...

Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis | Scientific ...

Nature.com - 30 Jan 2024
Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis | Scientific ... ...

Sustained Benefit for Newly Approved Myasthenia Gravis Drug in Early Responders

Medscape - 14 Nov 2023
Sustained Benefit for Newly Approved Myasthenia Gravis Drug in Early Responders ...

Myasthenia gravis